The malaria managers meeting was followed by the inter-country meeting of national malaria programme managers from HANMAT and PIAM-Net countries, which have ongoing Plasmodium falciparum malaria transmission.
The meeting updated participants on the monitoring efficacy of antimalarial medicines and the status of artemisinin resistance. It also provided an opportunity to share new therapeutic efficacy data from the sentinel sites and plan for the next round of therapeutic efficacy studies.
The meeting ended with recommendations for all countries to: review and update their antimalarial drug policy; continue and strengthen monitoring in vivo efficacy of first and second line drugs and other potential drugs; and consider inclusion of all annual Plasmodium falciparum cases due to the reduction of cases in several sites in countries controlling malaria.
